Literature DB >> 1779984

Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum.

G L Jones1, H M Edmundson, R Lord, L Spencer, R Mollard, A J Saul.   

Abstract

The 51-kDa merozoite surface antigen MSA2 of Plasmodium falciparum shows considerable strain-dependent polymorphism. Although marked sequence variation occurs in the central region of the molecule, the N and C-terminal sequences are highly conserved. A number of monoclonal antibodies directed against MSA2 have been described which inhibit parasite growth in vitro, but these are all directed against variable regions. In an attempt to raise strain independent antibodies we have prepared peptide-diphtheria toxoid (DT) constructs from 36 N-terminal octapeptides spanning the constant region and extending into the variable region of the FCQ/27 PNG variant staggered by one amino acid at either end. Similarly, we prepared 26 C-terminal octapeptides spanning the C-terminal constant region as well as 10 octapeptides from the variable region of the Indochina I variant MSA2. Most of the peptides elicited antipeptide titres in excess of 1/10(4) when administered to mice as peptide-DT adducts emulsified with Freund's complete adjuvant. Only 3 of the 43 N- and C-terminal constant region peptides elicited antibodies which reacted appropriately on immunofluorescence (IFA) or immunoblotting analysis with the intact MSA2 of both strains studied (FCQ/27 and Indochina I), whereas 3 other peptides from the variable region elicited antibodies reactive with the parent MSA2 only. Peptide constructs eliciting antibodies recognising the intact protein corresponded to elements in the cognate sequence of high antigenicity as predicted by the Jameson and Wolf algorithm.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779984     DOI: 10.1016/0166-6851(91)90158-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  7 in total

1.  Familial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso.

Authors:  C Aucan; Y Traoré; F Fumoux; P Rihet
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria.

Authors:  C Aucan; Y Traoré; F Tall; B Nacro; T Traoré-Leroux; F Fumoux; P Rihet
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Strain-specific humoral response to a polymorphic malaria vaccine.

Authors:  Christian Flück; Tom Smith; Hans-Peter Beck; Andrea Irion; Inoni Betuela; Michael P Alpers; Robin Anders; Allan Saul; Blaise Genton; Ingrid Felger
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Chemokine levels and parasite- and allergen-specific antibody responses in children and adults with severe or uncomplicated Plasmodium falciparum malaria.

Authors:  B Wangala; A Vovor; R G Gantin; Y F Agbeko; C J Lechner; X Huang; P T Soboslay; C Köhler
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

5.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

Authors:  P Ray; N Sahoo; B Singh; F A Kironde
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins.

Authors:  Jon Eric Tongren; Patrick H Corran; William Jarra; Jean Langhorne; Eleanor M Riley
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate.

Authors:  Rodrigo A V Morales; Christopher A MacRaild; Jeffrey Seow; Bankala Krishnarjuna; Nyssa Drinkwater; Romain Rouet; Robin F Anders; Daniel Christ; Sheena McGowan; Raymond S Norton
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.